Efficacy of prednisone combined with mycophenolate mofetil for immunoglobulin A nephropathy with moderate-to-severe renal dysfunction

doi:10.12998/wjcc.v11.i35.8300

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 35

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1951)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

118

WORD

HTML

977

Figures (1-2)

158

Tables (1-5)

164

Sum=1439

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

110

Download

320

Sum=430

Dec 16, 2023 (publication date) through Jan 26, 2025

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Dec 16, 2023; 11(35): 8300-8309
Published online Dec 16, 2023. doi: 10.12998/wjcc.v11.i35.8300

Table 4 Prognosis of patients in the two groups

Project	GTG	ITG	χ²	P value
Renal endpoint	14	7
Serious infection	4	2
Serious liver injury	4	2
Serious complication	10	8
Incidence of endpoint events	32%	19%	4.448	0.035
Follow-up time (mo)	10.11 ± 3.09	11.07 ± 2.08	2.000	0.048

GTG: Glucocorticoid therapy group; ITG: Immunosuppressive therapy group.

Citation: Meng MJ, Hu L, Fan Y, Gao H, Chen HZ, Chen CM, Qi Z, Liu B. Efficacy of prednisone combined with mycophenolate mofetil for immunoglobulin A nephropathy with moderate-to-severe renal dysfunction. World J Clin Cases 2023; 11(35): 8300-8309
URL: https://www.wjgnet.com/2307-8960/full/v11/i35/8300.htm
DOI: https://dx.doi.org/10.12998/wjcc.v11.i35.8300